Lirentelimab for severe and chronic forms of allergic conjunctivitis

Journal of Allergy and Clinical Immunology(2022)

引用 11|浏览6
暂无评分
摘要
Lirentelimab was well tolerated, improved severe AC and concomitant atopic symptoms, and reduced inflammatory mediators in patient tears.
更多
查看译文
关键词
AK002,sialic acid–binding immunoglobulin-like lectin-8,perennial allergic conjunctivitis,atopic keratoconjunctivitis,vernal keratoconjunctivitis,allergic conjunctival diseases,ocular allergy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要